Poolbeg Pharma plc

Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to fund the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members of the Amryt Pharma plc leadership team, with the intention of...

Cancer immunotherapy,oncology,glp-1 agonist,obesity,rsv,influenza,oral vaccines,oral glp-1,metabolic conditions,artificial intelligence,and ai

Poolbeg pharma plc operates in the Biotechnology research industry.

Poolbeg pharma plc's revenue is 11m - 100m

Poolbeg pharma plc has 11 - 50 employees.